Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
about
Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Role and regulation of β-catenin signaling during physiological liver growthAltered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomyFibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosisRegulation of fibroblast lipid storage and myofibroblast phenotypes during alveolar septation in micePathobiology of liver fibrosis: a translational success storyIncreased iron loading induces Bmp6 expression in the non-parenchymal cells of the liver independent of the BMP-signaling pathway.Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cellsWnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate CellsFerritin upregulates hepatic expression of bone morphogenetic protein 6 and hepcidin in mice.Supplements of vitamins B9 and B12 affect hepatic and mammary gland gene expression profiles in lactating dairy cowsPodoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liverCross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Epigenetics in radiation-induced fibrosis.Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis.Metabolic reprogramming and cell fate regulation in alcoholic liver disease.Morphogen-related therapeutic targets for liver fibrosis.Liver progenitor cells-mediated liver regeneration in liver cirrhosis.A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells.Hepatic stellate cells as key target in liver fibrosis.IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.Activation of hepatic stellate cell in Pten null liver injury model.2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis.Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia/reperfusion injury.Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK.
P2860
Q26829662-C41C44E3-4666-4DE9-918F-004DD3387FB3Q26864289-6942CAB4-AB0B-453C-B837-A2060D376404Q33720930-82621686-3376-4BF0-B7E1-9601685B003EQ34309876-D9153F70-ECA2-4C9B-9D12-7E54798CF2F2Q34323121-B6E403EF-818E-415C-9264-1A54EFCAF74AQ34356467-C60A4B9E-3EF6-4B13-99C7-9DE55BB50DF8Q34462733-BC2AEC4A-9606-4503-99C4-B4F77A372321Q34658504-54712D49-10C7-42F8-96D8-E7642408690AQ35549547-88EC3C78-842E-4E4B-A720-CDE854585029Q36026774-E26B9B48-1A38-44A3-ACA8-B2F7A29BF48DQ36041975-3F807E6D-B321-4902-B044-6227BED37152Q36104321-737D43E9-32C2-4EB4-8C5D-1E2CD1B8D916Q36422657-510455F7-5D73-4FC5-A8EF-E67595853DC0Q37136259-CDEF8A24-FD6D-489F-98AB-AB57A7932CA3Q38018841-85ABE6FC-BF17-4010-AD4B-7BB1E242AD2CQ38218535-E657BDE1-EB3D-40A9-8C64-BDB7F3DB6988Q38363814-49B88EA5-F084-47EE-863F-9CF520A159C6Q38387716-6B81442E-876E-4C4E-B94C-D32C81E0281CQ38553312-1CD8A639-CF1E-4345-B085-E9B91145AA65Q38689703-00932203-C712-496A-88A9-5FD2B597451AQ38917207-F94DFCEC-B141-41A2-9593-BAD55885B53CQ40200602-6F7C7341-DD70-4F7D-992C-BCAB7E35A741Q40478066-F4A718B0-94A9-42D1-9AFE-268E191C827CQ41933634-AA2295DD-F05C-4B4C-9387-8BB5585588AFQ45891714-9A240991-24F8-4A77-8FB3-B7DF4D912D08Q49379771-58462085-57CF-4BAF-8CF0-30123C78E62AQ49918430-4DB0492A-E77C-45DB-BA87-C42B52A18E61Q51297923-9062CC4A-C72E-46EB-A61E-0B043D7341E7
P2860
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
@ast
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
@en
type
label
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
@ast
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
@en
prefLabel
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
@ast
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
@en
P2093
P2860
P356
P1476
Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.
@en
P2093
Akiko Ueno
Atsushi Miyajima
Hidekazu Tsukamoto
Jiaohong Wang
Kinji Asahina
Nian-Ling Zhu
Raul Lazaro
Yuichiro Miyaoka
P2860
P304
10355-10367
P356
10.1074/JBC.M111.312751
P407
P577
2012-02-01T00:00:00Z